08 Mar 2023

Interview with Victoria Statham, VP Intellectual Property & Legal, Therapeutics

Blogs

24 Feb 2023

Therapeutics Science Day recording and presentations

Investors | Therapeutics

23 Feb 2023

Avacta Therapeutics Division Science Day

Investors | Therapeutics

17 Jan 2023

Avacta Announces Successful Completion of Fourth Dose Escalation in AVA6000 Phase 1 Clinical Study

Investors | Therapeutics

19 Dec 2022

Avacta to Host Therapeutics Division Science Day on 23rd February 2023

Investors | Therapeutics

08 Nov 2022

Director/PDMR Shareholding

Investors

08 Nov 2022

Result of the Open Offer

Investors

31 Oct 2022

Avacta to Present at Virtual Theranostics FAP Summit

Investors | Therapeutics

28 Oct 2022

Block Listing Six Monthly Return

Investors

20 Oct 2022

Director/PDMR Shareholding

Investors